SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex ($CETX) is trending due to a massive premarket surge and multiple trading halts, sparking high volatility. Community chatter revolves around a potential short squeeze reminiscent of $SMX and predictions of continued upward momentum, with some suggesting extremely high price targets. The stock's nano float and recent acquisition news are also fueling the discussion.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

Treasure Global is trending due to a recent revenue target update and chatter around its low float, sparking comparisons to other high-flying stocks like $SMX. Community members are actively discussing the potential for a significant short squeeze, citing high borrow rates and limited share availability. Some investors believe the stock could reach new highs, while others caution about the risks associated with low-float stocks and potential dilution.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending as investors debate the impact of competitor GPCR's data, particularly focusing on the lack of safety data released and potential implications for Viking's market position. Community discussions revolve around potential partnerships or a buyout, with some emphasizing Viking's strong pipeline and advanced stage in development. There is also ongoing speculation about the possibility of VK2809 skipping Phase 3 trials based on new FDA guidance.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences ($WVE) is trending following positive Phase 1 data for its obesity drug, WVE-007, which showed fat loss without muscle loss. The community is excited about the potential for infrequent dosing and is speculating about a possible offering or buyout. Discussions revolve around the significance of the data, potential price targets, and whether this is a Reddit-driven short squeeze.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending due to its impending inclusion in the S&P 500, driving significant after-hours price movement. While some investors celebrate the milestone and anticipate further gains, others express concerns about the company's fundamentals and accounting practices, suggesting a potential "sell the news" event. Community discussions revolve around whether the stock is overvalued and if a substantial correction is on the horizon.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd

SUGP is trending as traders discuss its potential for a low-float squeeze, drawing comparisons to recent runners in the same sector like $SMX. The community is analyzing the stock's float and short borrow fee, with some expressing caution due to a recent offering and warrant dilution. Overall, the focus remains on whether it can achieve a similar explosive move based on its low float.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery ($WBD) is trending amid a potential takeover, with Paramount ($PARA) launching a hostile bid, challenging Netflix's ($NFLX) deal and igniting a bidding war. Community discussion revolves around the merits of each offer, regulatory hurdles, and potential outcomes for shareholders. The stock has seen significant gains YTD, fueled by M&A rumors and speculation.

PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed, Braeden William Lichti, and Jordan R. Plews on June 9, 2020 and is headquartered in Newport Beach, CA.

PMGC Holdings Inc

PMGC Holdings Inc.

ELAB is trending due to a premarket surge, fueled by retail trader interest in PMGC Holdings' shift towards biotech and industrial sectors. Community discussions revolve around the stock's low float and potential for a squeeze, while some traders are pointing to possible overextension. The stock's volatility and previous reverse splits are also being discussed.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

GPCR is trending following Phase 2 data highlighting weight loss percentages, though some investors are wary due to the omission of certain safety data in the initial report. The community is actively discussing the tolerability of the drug, particularly regarding liver enzyme elevations and adverse events like vomiting, while also speculating about potential short squeezes and comparisons to competitors like $LLY and $VKTX. Some see it as a potential acquisition target in the competitive GLP-1 space.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors discuss the potential for a buyout or strategic partnership, fueled by promising data in lung, prostate, and pancreatic cancers. Community talking points center on the company being significantly undervalued with a large short interest, positioning it for a potential squeeze. Some are pointing to a recent analyst upgrade and upcoming presentation as potential catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Magnite Inc. (MGNI) attracted strong retail chatter on Stocktwits on Monday as the shares of the omni-channel sell-side advertising platform provider jumped during the session.In Tuesday's early premarket session, the stock gave some of the gains as it traded down by over 0.50%.The New York-based company benefited from a positive analyst action, which sent its shares soaring by 14.31% on Monday, with the upside accompanied by more than twice the average volume.According to Investing.com, Rosenblatt Securities maintained a ‘Buy’ rating for&nbsp;<a href="https://stocktwits.com/symbol/MGNI">Magnite stock</a> and raised the price target to $39 from $18 on Monday.&nbsp;Analysts at the research firm expect the company to reap substantial benefits from the upcoming AdTech antitrust remedy and penalty phase against Alphabet, Inc.’s (GOOGL) (GOOG) Google.&nbsp;In late April, a judge ruled that Google violated U.S. antitrust laws by monopolizing the markets for publisher ad servers and ad exchanges, and by illegally tying its ad server to its ad exchange.The benefits that Rosenblatt estimates could accrue as early as 2026, the analysts said, adding that it sees earnings improvement from behavioral remedies and potential proceeds from settlements.&nbsp;Rosenblatt said the stock price hasn’t yet baked in the potential benefits.Additionally, analysts believe that the ruling against Google was strong, potentially withstanding appeals, if any, thereby creating a favorable environment for Magnite in the digital advertising ecosystem.Following Rosenblatt’s note, the message volume on the Magnite stream on Stocktwits increased by 6,800% over the 24 hours leading up to late Monday.&nbsp;Sentiment toward the stock remained ‘extremely bullish’ (79/100) by early Tuesday.<figure class="image"><img style="aspect-ratio:617/50;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_01_at_5_10_00_AM_png_03fb91a309.webp" alt="Screenshot 2025-07-01 at 5.10.00 AM.png" width="617" height="50"><figcaption>MGNI sentiment and message volume as of 5:10 a.m. ET, July 1 | source: Stocktwits</figcaption></figure>Magnite stock has gained over 51% this year, and it hit a multi-year high of $24.46 in Monday’s session.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-says-musk-would-head-back-home-to-south-africa-without-subsidies/chFW3YqRRrE">Trump Says Musk Would 'Head Back Home To South Africa' Without Subsidies — Tesla CEO Dares President To 'Cut It All'</a>

The Magnite logo is seen displayed on a smartphone screen.

Magnite Retail Chatter Spikes After Stock Hits Multi-Year Highs As Analyst Flags ‘Substantial’ Benefits From Google Adtech Antitrust Ruling

The benefits that Rosenblatt estimates could accrue as early as 2026, the analysts said, adding that it sees earnings improvement from behavioral remedies and potential proceeds from settlements. 

Equity

The benefits that Rosenblatt estimates could accrue as early as 2026, the analysts said, adding that it sees earnings improvement from behavioral remedies and potential proceeds from settlements. 


Atlassian Corp. (TEAM) stock has gained nearly 18% since the collaboration software services and tools provider reported a beat-and-raise quarter. An analyst said Friday he is “incrementally positive” on the stock but opted to stay on the sidelines.Macquarie analyst Steve Koenig upped his price target for <a href="https://stocktwits.com/symbol/TEAM">Atlassian stock</a> as the stellar fiscal year second-quarter performance prompted him to revise his estimates for the company upwardly.&nbsp;The analyst attributed the second-quarter beat to the conservative guidance approach, which accommodates macro and execution risks. He also noted that the company stuck with its conservative approach in its fiscal year 2025 guidance as new Chief Revenue Officer Brian Duffy took over the sales team.&nbsp;Koenig expects Atlassian to maintain its 2025 momentum, citing the stability in the quarterly revenue trends and the 15%-25% data center price increases on contracts renewing after Feb. 11.The analyst said, “We're incrementally more positive on the potential for continued momentum to set the company up for near-term outperformance and easier FY27 comparisons that don't require acceleration.He is also encouraged by the company’s ability to derive more value per seat, which will likely offset macro headwinds.That said, Koenig believes that the multiple now looks stretched. "We could become more constructive if we gain visibility into FY26 (upside) and/or a more attractive entry point for TEAM shares," he added.&nbsp;The updated price target of $317 suggests a less than 1% upside from current levels.Macquarie has a ‘Neutral’ rating on Atlassian stock.<figure class="image"><img style="aspect-ratio:632/138;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/team_sentiment_8b2dea7843.png" alt="team-sentiment.png" width="632" height="138"><figcaption>TEAM sentiment and message volume February 10, as of 2:17 am ET | Source:&nbsp;Stocktwits</figcaption></figure>On Stocktwits, retail sentiment toward Atlassian stock turned ‘extremely bullish’ from merely ‘bullish’&nbsp; a day ago. The message volume remained at ‘normal’ levels.Atlassian stock ended Friday’s session down 1.48% at $314.28. The stock has gained over 29% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/roblox-under-active-sec-investigation-report-says-retail-braces-for-further-stock-decline/ch53xNzRtX">Roblox Under Active SEC Investigation, Report Says: Retail Braces For Further Stock Decline</a>

The Jira Cloud by Atlassian app page is displayed on a smartphone in the Apple App Store in front of the Atlassian Corporation logo on October 31, 2024 in Chongqing, China. 

Atlassian Analyst ‘Incrementally Positive’ On Stock Yet Remains On Sidelines: Retail Turns Increasingly Bullish

 Analyst Steve Koenig expects Atlassian to maintain its 2025 momentum, citing the stability in the quarterly revenue trends and the proposed 15%-25% data center price increases.

FDTX
Fidelity Disruptive Technology ETF

Feed

News

Sentiment

Fundamentals

Info

Latest FDTX News

FDTXFidelity Disruptive Technology ETF